Views: 0 Author: Site Editor Publish Time: 2025-12-10 Origin: Site
In the synthesis of structurally complex pharmaceuticals, the ability to selectively protect a sensitive functional group and control the molecule's three-dimensional shape is paramount. 2-Chlormethyl-8-(1,1-dimethylethyl)-1,4-dioxaspiro[4.5]decan (CAS No. 118135-28-7) is a masterful example of a highly engineered synthetic intermediate.
This compound is highly valued in the production of complex, stereochemically defined drug candidates where absolute purity is non-negotiable.
The demand for CAS No. 118135-28-7 is driven by high-value, multi-step synthetic campaigns that require masked functional groups and rigid scaffolds.
The spiroketal derivative is essential for creating complex molecules where multiple reaction steps must occur without affecting a key carbonyl group. Once the side chain is built, the spiroketal is cleaved back to the ketone.
The conformational lock imposed by the tert-butyl group and the rigid dioxaspiro unit facilitates highly stereoselective reactions on the chloromethyl group, allowing for the precise construction of chiral centers.
This intermediate is a precursor in the routes to several complex molecules in areas like oncology, CNS agents, and highly selective receptor modulators. decane structure
The industrial significance of CAS No. 118135-28-7 lies in the difficulty of synthesizing and purifying a structure that combines a sensitive functional group (halide) and a sterically hindered spiroketal.
The major synthetic challenges include:
The formation of the 1,4-dioxaspiro[4.5]decane ring requires the coupling of the ketone with a suitable diol (often 3-chloro-1,2-propanediol), requiring anhydrous and controlled acidic conditions. The product's stability is sensitive to moisture and highly acidic/basic conditions.
Due to the C-2 substitution, the spiroketal ring can exist as different stereoisomers (cis/trans or enantiomers) depending on the diol precursor used. Industrial suppliers must verify and control the stereochemical purity to meet the specific requirements of the client's subsequent chiral synthesis.
The chloromethyl group is the reaction site. Trace impurities, particularly residual water or acid, can initiate decomposition, leading to the free alcohol or unwanted side products that poison downstream coupling reactions.
Sourcing this specific, complex spiroketal requires a partner with specialized expertise in protecting group chemistry, stereocontrol, and multi-step advanced organic synthesis.
The supplier must demonstrate deep knowledge of anhydrous ketal formation, ensuring the integrity and regiochemistry of the two rings.
The product must be supplied with ≥ 99.0% purity, critically controlling for residual water and the free ketone (hydrolyzed product).
Due to its application in API synthesis, the ability to operate under cGMP-aligned standards and guarantee specific stereochemical purity is paramount.
Only manufacturers specializing in high-value, complex heterocyclic and chiral API intermediates can reliably produce this compound at the required quality.
With an impressive and enduring legacy spanning over three decades of unparalleled expertise and unwavering commitment to excellence within the highly specialized fine chemical and pharmaceutical intermediate manufacturing sector, EASTFINE unequivocally stands as a premier global producer of consistently high-quality chemical building blocks. Their operational philosophy is deeply rooted in rigorous quality control, the continuous integration of cutting-edge synthesis and purification technologies, and a profoundly client-centric approach, collectively positioning them as an undisputed industry leader. For 2-Chlormethyl-8-(1,1-dimethylethyl)-1,4-dioxaspiro[4.5]decan, EASTFINE offers:
EASTFINE guarantees the supply of this spiroketal at an exceptional purity of typically ≥ 99.5%, meticulously verified by a suite of state-of-the-art analytical tests (GC, H-NMR) that focus on isomer ratio and residual ketone content.
Building on decades of specialized knowledge, EASTFINE possesses dedicated processes for the anhydrous formation of the spiroketal and the subsequent chlorination, ensuring the integrity of the tert-butyl-locked scaffold throughout the multi-step synthesis.
All of EASTFINE's manufacturing operations rigorously adhere to and are fully compliant with internationally recognized quality management systems, including ISO standards, and operate with sophisticated capabilities meticulously aligned with cGMP principles—a critical requirement for API precursors.
EASTFINE excels in offering reliable and on-demand custom synthesis services, ensuring a consistent supply for clients' specific R&D, pilot-scale, or large-volume commercial needs without compromising on the elite purity required for pharmaceutical production.
Beyond merely supplying chemicals, EASTFINE functions as a true strategic partner, providing expert technical assistance and comprehensive documentation packages required for process validation and the eventual deprotection step.
Specialized in API/cGMP Intermediates, noted for providing high regulatory compliant documentation and strict audit-ready processes, making them a strong choice when the product is used in pharmaceutical routes.
Focuses on High-Purity Research Reagents, offering smaller quantities of the spiroketal, primarily serving academic research and early-stage development.
Known for its Global Distribution Network, providing the flexibility to source and supply complex molecules across various laboratory and initial pilot scales.
Specialized in complex, high-value building blocks for drug discovery, often offering high-purity, low-volume amounts.
For an intermediate whose function is to protect a group while enabling stereoselective reactions, stability and isomeric purity are the highest measures of quality.
Choosing EASTFINE means partnering with a company that has strategically invested in mastering complex protection and rigid scaffold synthesis:
We ensure minimal hydrolysis products (the free ketone), allowing for maximum yield in your subsequent reactions on the chloromethyl group.
Our controlled synthesis guarantees the consistent conformation and purity required for successful stereoselective functionalization.
We provide a secure, cGMP-aligned supply chain, offering the confidence required for large-scale, long-term pharmaceutical manufacturing where complexity demands perfection.
2-Chlormethyl-8-(1,1-dimethylethyl)-1,4-dioxaspiro[4.5]decan (CAS No. 118135-28-7) is a strategic, high-value intermediate for advanced API synthesis. Its successful deployment hinges entirely on securing a supply that guarantees elite purity, structural integrity, and technical mastery. Partner with EASTFINE to ensure a secure, high-quality supply of this essential complex intermediate, backed by decades of expertise in critical fine chemical synthesis.
简体中文
